Scarica l'app Stockscreener
4.46
0.45%
-0.02
Dopo l'orario di chiusura:
4.45
-0.010
-0.22%
Precedente Chiudi:
$4.48
Aprire:
$4.37
Volume 24 ore:
17,959
Relative Volume:
0.68
Capitalizzazione di mercato:
$18.06M
Reddito:
-
Utile/perdita netta:
$-26.28M
Rapporto P/E:
-1.0398
EPS:
-4.2891
Flusso di cassa netto:
$-12.39M
1 W Prestazione:
-6.30%
1M Prestazione:
-64.15%
6M Prestazione:
-88.56%
1 anno Prestazione:
-91.66%
Intervallo 1D:
$4.20
$4.46
Intervallo di 1 settimana:
$4.1353
$4.99
Portata 52W:
$4.1353
$75.50
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Nome
Tevogen Bio Holdings Inc
Settore
Industria
Telefono
646-807-8832
Indirizzo
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
4.46 | 18.06M | 0 | -26.28M | -12.39M | -4.2891 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-04 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-03-04 | Iniziato | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Borsa (TVGN) Ultime notizie
TVGN Should I Buy - Intellectia AI
Buyout Rumor: Should you avoid Tevogen Bio Holdings Inc stock right now2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Tevogen Bio (NASDAQ: TVGN) maps T-cell therapy and Long COVID push - Stock Titan
Tevogen Bio Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Sectors: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysis2026 Action & Long Hold Capital Preservation Tips - baoquankhu1.vn
Tevogen Bio Holdings Inc.Common Stock (NQ: TVGN - FinancialContent
Aug Macro: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rate2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Volatility Watch: Is Tevogen Bio Holdings Inc stock a good pick for beginners2026 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Loss Report: Is Tevogen Bio Holdings Inc Equity Warrant stock heavily shortedMarket Trend Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Tevogen Bio Regains Nasdaq Compliance After Reverse Split - The Globe and Mail
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth - Bitget
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and ... - Bluefield Daily Telegraph
Tevogen Bio Holdings Inc. Files Form 8-K on NASDAQ: Company Details and Key Information for March 2026 - Minichart
Tevogen Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛
Tevogen Bio regains Nasdaq compliance following reverse stock split By Investing.com - Investing.com India
Tevogen Bio regains Nasdaq compliance following reverse stock split - Investing.com
Tevogen Bio Holdings regains Nasdaq bid-price compliance after 1-for-50 reverse split - TradingView
Nasdaq restores TVGN listing after 1-for-50 reverse split (TVGN) - Stock Titan
Tevogen Bio (TVGN) restores Nasdaq bid-price compliance after 1-for-50 reverse split - Stock Titan
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement - Bitget
Tevogen regains compliance with Nasdaq minimum bid price requirement - TipRanks
Tevogen Bio Regains Compliance With Nasdaq Listing Rule - MarketScreener
Tevogen Bio Holdings Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
Investment Report: Is Tevogen Bio Holdings Inc stock good for income investors2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Tevogen Bio Holdings Inc expected to post a loss of $2.00 a shareEarnings Preview - TradingView
Market Pulse: Why is Tevogen Bio Holdings Inc Equity Warrant stock going upWeekly Profit Analysis & Reliable Breakout Forecasts - baoquankhu1.vn
Revenue Check: Why is Tevogen Bio Holdings Inc Equity Warrant stock going up - baoquankhu1.vn
TVGN Technical Analysis & Stock Price Forecast - Intellectia AI
Tevogen Bio Holdings Inc. Announces CIO Mittul Mehta to Speak at Microsoft Fabric Community Conference 2026 on Data Engineering and AI - Quiver Quantitative
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) - Finviz
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community ... - Caledonian Record
Microsoft FabCon puts Tevogen AI chief on two data engineering panels - Stock Titan
Neal Flomenberg sells Tevogen Bio Holdings (TVGN) shares for $6.6k By Investing.com - Investing.com South Africa
Neal Flomenberg sells Tevogen Bio Holdings (TVGN) shares for $6.6k - Investing.com
Tevogen Bio (TVGN) officer sells 972 shares to cover tax obligations - Stock Titan
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - The Manila Times
Tevogen reports performance advancements for Tevogen.AI platform - TipRanks
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization - The Globe and Mail
Tevogen Bio Advances AI Drug Development Platform with Improved Predictive Accuracy for Target Identification - Quiver Quantitative
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics ... - bdtonline.com
Tevogen.AI Reports Advancements in PredicTcell Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - 富途牛牛
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform - Finviz
Wall Street Recap: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysisEarnings Overview Report & Real-Time Market Trend Scan - baoquankhu1.vn
Tevogen Bio Holdings Inc. is considering the acquisition of Sciometrix and Clinicus platforms to enhance its monitoring capabilities for Long Covid. - Bitget
Tevogen Bio Accelerates Development of TVGN 489 for Long COVID with New Leadership and Strategic Initiatives - Quiver Quantitative
Long COVID ‘clinical emergency’: Tevogen develops T-cell therapy for 65% of U.S. - Stock Titan
Tevogen Bio Holdings Inc Share Price USD0.0001 - Hargreaves Lansdown
Tevogen appoints interim leaders across core business verticals - TipRanks
Tevogen Bio Holdings Inc. Appoints Interim Leaders to Drive Diversified Growth Strategy - Quiver Quantitative
Tevogen Names Leadership Team to Execute Diversified Growth Strategy - GlobeNewswire
Free cash flow of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Tevogen Bio Holdings Inc Azioni (TVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):